Stock Scorer

Progyny, Inc. (PGNY) · Peers

Progyny against the 13 other companies here in its SEC industry, Services-Misc Health & Allied Services, Nec. Each figure is the one on the company's own page; the median is the peers', and the rank is among all 14, highest first.

Measure by measure

MeasurePGNYPeer medianRank
Market value $2.06B median $225.59M 4 of 13
P/E 26.2× median 24.9× 3 of 6
Forward P/E 12.9× median 12.6× 4 of 8
EV/EBITDA 15.5× median 10.3× 3 of 6
P/S 1.6× median 2.1× 8 of 13
FCF yield 8.7% median 2.2% 3 of 12
Gross margin 24.6% median 55.0% 7 of 10
Operating margin 8.6% median -0.5% 3 of 10
Net margin 6.0% median 2.8% 5 of 11
ROIC 40.9% median 6.4% 1 of 6
ROE 17.3% median 3.2% 3 of 10
Revenue growth (4y, yearly) 26.7% median 5.7% 3 of 10
EPS growth (yearly) -0.4% median 2.5% 5 of 6
Current ratio 2.1× median 1.6× 6 of 13
Stock pay / revenue 8.2% median 1.0% 4 of 14
Share count change -5.9% median 0.5% 9 of 10

Green where Progyny is on the better side of the median, red where on the worse; no colour where higher is neither, like size or dividend yield.

The peers, largest first

CompanyMarket valueP/EROICScore
PGNYProgyny, Inc. $2.06B P/E 26.2× 40.9% 6.9
DVADaVita HealthCare Partners Inc $11.95B P/E 14.1× 18.0% 6.0
FMSFresenius Medical Care AG $11.80B P/E – – 5.3
SHCSotera Health Co $5.11B P/E 31.2× – 4.8
AGLagilon health, inc. $1.43B P/E – – 4.4
MCTACharming Medical Ltd $474.08M P/E – – 3.1
VMDViemed Healthcare Inc $361.08M P/E 24.9× 12.8% 6.1
PARKPark Dental Partners, Inc. $90.11M P/E 94.0× – 5.2
MRAIMarpai, Inc. $83.98M P/E – – 2.4
BRTXBioRestorative Therapies, Inc. $39.24M P/E – – 3.6
CCELCryo Cell International Inc $35.64M P/E – – 5.1
PFHOPacific Health Care Organization Inc $12.03M P/E 12.3× 6.4% 5.5
MGRXMangoceuticals, Inc. $6.25M P/E – -77.3% 3.3
NIVFNewGenIvf Group Ltd – P/E – -32.4% 5.5

The industry is the Standard Industrial Classification code the company registered with the SEC. It is a broad label: a peer group is a starting point for comparing, not proof that two businesses are alike. None of this is advice.